# DrugCendR Inc. — Form D

DrugCendR Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-22. $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-02-22
- Form: D
- Accession: 0001729308-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $1.0M
- Minimum investment: $30K
- Investors: 5
- Date of first sale: 2017-03-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-306253

## Issuer

- Name: DrugCendR Inc.
- CIK: 0001729308
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2016
- Address: 10901 N TORREY PINES RD, LA JOLLA, CA, 92037
- Phone: 8586463101

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Erkki Ruoslahti | Executive Officer | La Jolla, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-05-29](https://search.stillhousedata.com/formd/0001729308-18-000004) | D | $1.5M | $1.1M |

## More

- [CIK 1729308 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1729308&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001729308-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.